Effects of oral contraceptive pills on mood and magnetic resonance imaging measures of prefrontal cortical thickness
- PMID: 33420480
- PMCID: PMC7914152
- DOI: 10.1038/s41380-020-00990-2
Effects of oral contraceptive pills on mood and magnetic resonance imaging measures of prefrontal cortical thickness
Abstract
Gonadal hormones influence neuronal organization and plasticity. Yet the consequences of altering their concentrations by administering contraceptive agents, which are used by most reproductive-age women in the United States, are unclear. Cross-sectional studies have found both larger and smaller cortical regions alongside a variety of mood alterations in women who use oral contraceptive pills (OCPs) compared to naturally-cycling women. The goal of this study, therefore, was to determine whether there is an effect of OCPs on MRI measures of prefrontal cortical brain structure that may influence regulation of mood. We performed a double-blind, placebo-controlled, randomized crossover study comparing effects of OCPs (0.15 mg levonorgestrel + 0.30 μg ethinyl estradiol) vs placebo (N = 26) on MRI measures of prefrontal cortical thickness and on mood, as indicated by self-report on the Daily Record of Severity of Problems, which also includes one item related to somatic symptoms. MRI measures that reflect cortical thickness were smaller bilaterally in the pars triangularis and in the pars opercularis and frontal pole of the right hemisphere during the OCP arm vs. placebo. Only the effect in the right pars triangularis survived multiple comparisons correction. Right pars triangularis MRI measures of cortical thickness were not related to mood symptoms, but negatively correlated across conditions with severity of somatic symptoms on the DSRP. The somatic symptoms and MRI measures may be independently related to the actions of steroid hormones in OCPs, with OCPs simultaneously inducing both more effects on MRI measures of cortical thickness and somatic symptoms.
Conflict of interest statement
Figures



Similar articles
-
Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2874-80. doi: 10.1152/ajpheart.00762.2006. Epub 2007 Feb 2. Am J Physiol Heart Circ Physiol. 2007. PMID: 17277029 Clinical Trial.
-
A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.J Psychosom Res. 1992 Apr;36(3):257-66. doi: 10.1016/0022-3999(92)90090-o. J Psychosom Res. 1992. PMID: 1564678 Clinical Trial.
-
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.Br J Obstet Gynaecol. 1993 Sep;100(9):832-8. doi: 10.1111/j.1471-0528.1993.tb14309.x. Br J Obstet Gynaecol. 1993. PMID: 8218004 Clinical Trial.
-
The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.Contraception. 1986 Nov;34(5):513-22. doi: 10.1016/0010-7824(86)90060-0. Contraception. 1986. PMID: 3102162
-
Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.Contraception. 1988 Jul;38(1):27-35. doi: 10.1016/0010-7824(88)90093-5. Contraception. 1988. PMID: 3139358 Review.
Cited by
-
Morphologic alterations of the fear circuitry: the role of sex hormones and oral contraceptives.Front Endocrinol (Lausanne). 2023 Nov 7;14:1228504. doi: 10.3389/fendo.2023.1228504. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027091 Free PMC article.
-
The impact of 17β-estradiol on the estrogen-deficient female brain: from mechanisms to therapy with hot flushes as target symptoms.Front Endocrinol (Lausanne). 2024 Jan 8;14:1310432. doi: 10.3389/fendo.2023.1310432. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260155 Free PMC article. Review.
-
Editorial: Effects of hormonal contraceptives on the brain.Front Endocrinol (Lausanne). 2023 Jan 31;14:1129203. doi: 10.3389/fendo.2023.1129203. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36798667 Free PMC article. No abstract available.
-
Hormonal contraceptives and the brain: A systematic review on 60 years of neuroimaging, EEG, and biochemical studies in humans and animals.Front Neuroendocrinol. 2023 Jan;68:101051. doi: 10.1016/j.yfrne.2022.101051. Epub 2022 Dec 25. Front Neuroendocrinol. 2023. PMID: 36577486 Free PMC article.
-
Effects of Oral Contraceptive Pills on Brain Networks: A Conceptual Replication and Extension.Hum Brain Mapp. 2025 Aug 1;46(11):e70318. doi: 10.1002/hbm.70318. Hum Brain Mapp. 2025. PMID: 40782033 Free PMC article. Clinical Trial.
References
-
- Taggart TC, Eaton NR, Keyes KM, Hammett JF, Ulloa EC. Oral contraceptive use is associated with greater mood stability and higher relationship satisfaction. Neurology, Psychiatry and Brain Research 2018; 30: 154–162.
-
- Hamstra DA, de Kloet ER, de Rover M, Van der Does W. Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study. Journal of Psychosomatic Research 2017; 103: 119–126. - PubMed
-
- Keyes KM, Cheslack-Postava K, Westhoff C, Heim CM, Haloossim M, Walsh K et al. Association of Hormonal Contraceptive Use With Reduced Levels of Depressive Symptoms: A National Study of Sexually Active Women in the United States. American Journal of Epidemiology 2013; 178(9): 1378–1388. - PMC - PubMed
-
- Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of Hormonal Contraception With Depression. JAMA Psychiatry 2016; 73(11): 1154–1162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous